In Brief: FDA Reproductive Health Drugs Advisory Committee

Executive Summary

FDA Reproductive Health Drugs Advisory Committee: Postcoital emergency use of "certain" oral contraceptives will be discussed by committee (formerly the Fertility & Maternal Health Drugs Advisory Committee) June 28. FDA received a citizen's petition from the Center for Reproductive Law & Policy in November 1994 requesting inclusion of the use in OC labeling. FDA denied the petition but "determined that it would be appropriate to discuss the scientific issues related to the safety and effectiveness of this use." The meeting will begin at 9 a.m. at the Holiday Inn, Gaithersburg, Md...